Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of authorisation: 24/01/2003, Revision: 21, Status: Authorised
Cancer Medicines Forum
Mandate, objectives and rules of procedure for the Cancer Medicines Forum
Bimervax: Periodic safety update report assessment 30 September 2024 - 29 March 2025
Concept paper on the guideline revision on good pharmacogenomic practice
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 November 2025, 09:00 (CET) to 18 November 2025, 17:30 (CET)
Meeting summary - PCWP/HCPWP and all eligible organisations meeting 18 November 2025
Human medicines European public assessment report (EPAR): Inbrija, levodopa, Date of authorisation: 19/09/2019, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
List of substances and products subject to worksharing for signal management